State Street’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$185M Buy
8,332,771
+422,038
+5% +$10.1M 0.01% 983
2025
Q4
$211M Buy
7,910,733
+655,257
+9% +$15.7M 0.01% 906
2025
Q3
$155M Buy
7,255,476
+1,077,432
+17% +$25.5M 0.01% 1098
2025
Q2
$133M Sell
6,178,044
-815,469
-12% -$15.2M 0.01% 1152
2025
Q1
$116M Buy
6,993,513
+2,472,128
+55% +$44.9M ﹤0.01% 1183
2024
Q4
$83M Sell
4,521,385
-1,452,489
-24% -$23.4M ﹤0.01% 1452
2024
Q3
$91.9M Buy
5,973,874
+173,084
+3% +$2.89M ﹤0.01% 1374
2024
Q2
$94.3M Sell
5,800,790
-200,613
-3% -$3.24M ﹤0.01% 1300
2024
Q1
$111M Sell
6,001,403
-463,623
-7% -$11.5M 0.01% 1241
2023
Q4
$202M Buy
6,465,026
+1,251,295
+24% +$29.9M 0.01% 836
2023
Q3
$109M Sell
5,213,731
-206,587
-4% -$5.61M 0.01% 1128
2023
Q2
$130M Sell
5,420,318
-166,543
-3% -$3.7M 0.01% 1051
2023
Q1
$105M Sell
5,586,861
-2,153,477
-28% -$41M 0.01% 1154
2022
Q4
$123M Buy
7,740,338
+961,467
+14% +$15M 0.01% 1042
2022
Q3
$111M Buy
6,778,871
+184,921
+3% +$2.99M 0.01% 1047
2022
Q2
$92.9M Buy
6,593,950
+1,536,756
+30% +$28.7M 0.01% 1211
2022
Q1
$122M Buy
5,057,194
+237,241
+5% +$5.74M 0.01% 1153
2021
Q4
$112M Sell
4,819,953
-908,370
-16% -$18.3M 0.01% 1202
2021
Q3
$95.1M Buy
5,728,323
+1,757,712
+44% +$33.9M 0.01% 1307
2021
Q2
$96.8M Buy
3,970,611
+761,973
+24% +$17.2M 0.01% 1320
2021
Q1
$82.8M Buy
3,208,638
+598,812
+23% +$26.4M ﹤0.01% 1377
2020
Q4
$140M Sell
2,609,826
-92,758
-3% -$4.6M 0.01% 917
2020
Q3
$111M Buy
2,702,584
+134,840
+5% +$5.82M 0.01% 909
2020
Q2
$124M Sell
2,567,744
-1,474,552
-36% -$70.8M 0.01% 837
2020
Q1
$171M Buy
4,042,296
+38,619
+1% +$1.59M 0.01% 656
2019
Q4
$171M Buy
4,003,677
+548,277
+16% +$23.9M 0.01% 758
2019
Q3
$124M Sell
3,455,400
-1,189,463
-26% -$36.1M 0.01% 879
2019
Q2
$124M Sell
4,644,863
-220,834
-5% -$5.64M 0.01% 895
2019
Q1
$131M Buy
4,865,697
+26,511
+0.5% +$619K 0.01% 856
2018
Q4
$78.3M Sell
4,839,186
-1,999,013
-29% -$38.8M 0.01% 1048
2018
Q3
$142M Buy
6,838,199
+1,011,324
+17% +$15.9M 0.01% 861
2018
Q2
$89M Buy
5,826,875
+1,651,126
+40% +$29.4M 0.01% 1119
2018
Q1
$93.8M Buy
4,175,749
+852,811
+26% +$23.6M 0.01% 1042
2017
Q4
$100M Buy
3,322,938
+82,559
+3% +$2.64M 0.01% 1009
2017
Q3
$122M Sell
3,240,379
-508,089
-14% -$16.5M 0.01% 878
2017
Q2
$105M Buy
3,748,468
+510,670
+16% +$15.2M 0.01% 943
2017
Q1
$111M Sell
3,237,798
-116,228
-3% -$4.1M 0.01% 881
2016
Q4
$96.7M Buy
3,354,026
+246,198
+8% +$6.51M 0.01% 924
2016
Q3
$98.9M Buy
3,107,828
+832,503
+37% +$28.2M 0.01% 881
2016
Q2
$73.9M Sell
2,275,325
-1,089,101
-32% -$36.4M 0.01% 982
2016
Q1
$94.1M Buy
3,364,426
+997,205
+42% +$21.7M 0.01% 865
2015
Q4
$84.4M Buy
2,367,221
+379,117
+19% +$13.4M 0.01% 895
2015
Q3
$65.7M Buy
1,988,104
+63,016
+3% +$2.62M 0.01% 1015
2015
Q2
$80.6M Sell
1,925,088
-4,522
-0.2% -$175K 0.01% 971
2015
Q1
$62.9M Buy
1,929,610
+139,984
+8% +$4.81M 0.01% 1110
2014
Q4
$56.8M Sell
1,789,626
-97,391
-5% -$2.76M 0.01% 1158
2014
Q3
$46.7M Sell
1,887,017
-103,408
-5% -$2.42M 0.01% 1215
2014
Q2
$45M Sell
1,990,425
-33,906
-2% -$708K ﹤0.01% 1285
2014
Q1
$49.3M Buy
2,024,331
+90,216
+5% +$2.28M 0.01% 1205
2013
Q4
$48.3M Sell
1,934,115
-174,765
-8% -$4.12M 0.01% 1213
2013
Q3
$57.9M Buy
2,108,880
+140,938
+7% +$2.95M 0.01% 1074
2013
Q2
$35.7M Buy
+1,967,942
New +$27.1M ﹤0.01% 1295

Other funds holding ACAD